Filing Details
- Accession Number:
- 0001209191-16-119601
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-12 16:57:41
- Reporting Period:
- 2016-05-10
- Filing Date:
- 2016-05-12
- Accepted Time:
- 2016-05-12 16:57:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1649245 | G. Phillip Febbo | 301 Penobscot Dr. Redwood City CA 94063 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2016-05-10 | 6,224 | $27.19 | 15,113 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-05-10 | 100 | $28.13 | 15,013 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on March 9, 2016.
- Represents weighted average sale price. Actual sale prices ranged from $26.56 to $27.55.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Includes an aggregate of 13,948 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- Represents actual sale price.
Billionaire Hedge Funds
